Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Exp Neurol. 2015 Dec 2;285(Pt B):136–146. doi: 10.1016/j.expneurol.2015.12.001

Table 1.

Drugs and the effects on bladder non-voiding contractions (NVC) in SCI rats.

Drugs Types* Dose (mg/kg) Rats Bladder NVC
Saline Drugs
Flupenthixol Non-selective DR antagonist 1.2
2.4		 N = 6 2.3 ± 0.6 0.9 ± 0.2*
0.7 ± 0.2**
SKF 38393 D1-like receptor agonist 3.0 N = 4 1.5 ± 0.7 1.9 ± 0.7
SCH 23390 D1-like receptor antagonist 3.0 N = 6 1.7 ± 0.6 1.5 ± 0.7
Quinpirole D2-like receptor agonist 0.1 N = 6 2.4 ± 0.6 2.3 ± 0.5
Remoxipride D2-like receptor antagonist 1.0 N = 4 2.6 ± 0.7 2.6 ± 1.6

DR, dopamine receptor.

*

p = 0.09 compared to saline administration.

**

p < 0.05 compared to saline administration.